These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30604627)

  • 1. Identification of CAV1 and DCN as potential predictive biomarkers for lung adenocarcinoma.
    Yan Y; Xu Z; Qian L; Zeng S; Zhou Y; Chen X; Wei J; Gong Z
    Am J Physiol Lung Cell Mol Physiol; 2019 Apr; 316(4):L630-L643. PubMed ID: 30604627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
    Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
    Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
    Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis.
    Wang W; He J; Lu H; Kong Q; Lin S
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32519739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased HLF Expression Predicts Poor Survival in Lung Adenocarcinoma.
    Wang Z; Li X; Chen H; Han L; Ji X; Wang Q; Wei L; Miao Y; Wang J; Mao J; Zhang Z
    Med Sci Monit; 2021 May; 27():e929333. PubMed ID: 33979320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.
    Dong S; Men W; Yang S; Xu S
    Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
    Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of KIF4A and its effect on the progression of lung adenocarcinoma based on the bioinformatics analysis.
    Song Y; Tang W; Li H
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33398330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis identifies YKT6 as a potential prognostic and diagnostic biomarker in lung adenocarcinoma.
    Zhang L; Wang S; Wang L
    BMC Cancer; 2024 Oct; 24(1):1235. PubMed ID: 39375639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma.
    Fei H; Chen S; Xu C
    Biomed Res Int; 2020; 2020():8931419. PubMed ID: 33062704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
    Yu Y; Tian X
    Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
    Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
    Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma.
    Zhou LN; Li SC; Li XY; Ge H; Li HM
    Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification Six Metabolic Genes as Potential Biomarkers for Lung Adenocarcinoma.
    Zhang S; Lu Y; Liu Z; Li X; Wang Z; Cai Z
    J Comput Biol; 2020 Oct; 27(10):1532-1543. PubMed ID: 32298601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of differentially expressed genes associated with lung adenocarcinoma via bioinformatics analysis.
    Yang X; Feng Q; Jing J; Yan J; Zeng Z; Zheng H; Cheng X
    Gen Physiol Biophys; 2021 Jan; 40(1):31-48. PubMed ID: 33655889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The screening of immune-related biomarkers for prognosis of lung adenocarcinoma.
    Liu Z; Sun D; Zhu Q; Liu X
    Bioengineered; 2021 Dec; 12(1):1273-1285. PubMed ID: 33870858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
    Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.